Skip to Content
Merck
CN
  • Identification of urinary metabolites of the red clover isoflavones formononetin and biochanin A in human subjects.

Identification of urinary metabolites of the red clover isoflavones formononetin and biochanin A in human subjects.

Journal of agricultural and food chemistry (2004-10-28)
Satu-Maarit Heinonen, Kristiina Wähälä, Herman Adlercreutz
ABSTRACT

Dietary supplements manufactured from red clover are widely marketed to provide the beneficial health effects of isoflavones without changing the original diet. In this study the metabolism of formononetin and biochanin A, the principal isoflavones of red clover, was studied in human subjects. Seven women ingested four red clover dietary supplements, and the metabolites of the isoflavones were identified in their urine samples. The structures of trimethylsilyl derivatives of the metabolites were established by GC-MS. New reduced metabolites of formononetin (dihydroformononetin and angolensin) and biochanin A (dihydrobiochanin A and 6'-hydroxyangolensin) were identified in urine samples using authentic reference compounds. Possible metabolic pathways are presented for the red clover isoflavones formononetin and biochanin A.

MATERIALS
Product Number
Brand
Product Description

Supelco
Genistein, analytical standard
Sigma-Aldrich
Glycitein, ≥97% (HPLC)
Sigma-Aldrich
Genistein, synthetic, ≥98% (HPLC), powder
Sigma-Aldrich
Genistein, from Glycine max (soybean), ~98% (HPLC)
Sigma-Aldrich
Formononetin, ≥99.0% (TLC)
Supelco
Daidzein, analytical standard
Sigma-Aldrich
Biochanin A
Sigma-Aldrich
Daidzein, ≥98%, synthetic